Balancing Patient Convenience with Environmental Protection

Kiran Mazumdar –Shaw, CMD Biocon There are nearly half a billion diabetes patients in the world today and by 2040 that number is expected to climb to over 640 million. Even as diabetes incidence grows across the globe, developed markets like the U.S. are grappling with astronomical prices of one of the key medications for … Continue reading Balancing Patient Convenience with Environmental Protection

My address to Biocon Women Employees on International Women’s Day 2019

Today, as the first women employee of Biocon, I celebrate a lot of things done right at Biocon in last 40 years. When I started Biocon in 1978, there were very few women keen in business space.  I was perhaps the first tech startup in India because IT came to India a little later after … Continue reading My address to Biocon Women Employees on International Women’s Day 2019

A Journey of Endurance

By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance

India To Be A Biotech Hot Spot

The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s own rapidly advancing economy and rising global status. We have successfully leveraged recombinant DNA technology to deliver biopharmaceuticals, vaccines, genetically engineered crops and enzymes. In doing so, we have created a notable bio-economy valued at $35 billion. We have embraced … Continue reading India To Be A Biotech Hot Spot

Biocon Advances In War Against Diabetes

There are nearly half a billion diabetes patients in the world. The alarming growth in the global diabetes population is leading to a huge demand for effective therapies from pre/early diabetes to late-stage disease. Of the 100 million people who need insulin globally, however, only ‘one in two’ can manage and afford costs associated with … Continue reading Biocon Advances In War Against Diabetes

A Collaborative Approach to Healthcare Delivery

The highest attainable standard of health is a fundamental right of every human being. In this context, universal access to healthcare assumes prime importance. However, healthcare delivery poses a significant challenge for policymakers in India. A severe lack of resources means that there is only one doctor per 1,700 citizens in India, well below the … Continue reading A Collaborative Approach to Healthcare Delivery

Ensuring World Class Affordable Cancer Care

This video captures the highlights of the daylong NDTV Fortis CANCERTHON campaign telecasted on Sunday, Feb 8th, 2015. The initiative, focused on creating awareness on Cancer and raising funds to support treatment of children suffering with Cancer. This video talks about the affordable Cancer Care model at the Mazumdar Shaw Cancer Centre. Kiran Mazumdar Shaw … Continue reading Ensuring World Class Affordable Cancer Care

Why FY14 was a Remarkable Year for Biocon

The fiscal year gone by has been one of the most exciting ones for Biocon. We delivered on our promise of affordable innovation, recorded robust top line and bottom line growth, augmented our capacities, optimized our product portfolio and introduced initiatives to achieve operational efficiencies. We successfully commercialized two world-class, low-cost monoclonal antibodies, an outcome … Continue reading Why FY14 was a Remarkable Year for Biocon